Reven Pharmaceuticals Reven Pharmaceuticals
homepage 2017-11-29T10:03:28+00:00


is a global healthcare company with more than

10 years of innovation and leadership in vascular care.

Reven currently has an active Phase 1 Clinical Trial being conducted in the United States. Reven has completed the single-ascending-dose (SAD) portion of the study and are half-way through the multiple-ascending-dose (MAD) portion of the study. The Clinical Trial will be completed in January 2019.